Puma Biotechnology
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Puma Biotechnology generated cash of $27,009,000, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore $7,884,000.
Cash Flow
| 2014 | -77.2M | -63.3M | 136M |
|---|---|---|---|
| 2015 | -154.5M | -85.9M | 233.36M |
| 2016 | -141.7M | 142.2M | 162.4M |
| 2017 | -172.5M | -15.4M | 75.1M |
| 2018 | -24.1M | -57.6M | 108.4M |
| 2019 | 22.4M | 5.2M | -67.1M |
| 2020 | 800K | 23.3M | 100K |
| 2021 | 20.7M | -10.9M | -31.9M |
| 2022 | -15.8M | 7.1M | 12.2M |
| 2023 | 27.00M | -19.12M | 0 |
PBYI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 78.79M | 75.29M | 97.45M | 73.21M | 112.73M | 86.01M | 194.49M | 31.56M | 38.53M | 43.04M |
Operating activities | ||||||||||
Net income | 21.59M | 2K | -29.12M | -59.99M | -75.59M | -113.57M | -291.95M | -276.01M | -239.28M | -141.96M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 11.51M | 8.92M | 10.59M | 10.03M | 8.07M | 7.38M | 2.81M | 1.14M | 776K | 627K |
Stock-based compensation expense | 10.24M | 11.82M | 32.63M | 36.57M | 57.32M | 0 | 108.73M | 117.26M | 94.93M | 39.15M |
| Deferred income tax benefit | 10.24M | 11.82M | 32.63M | 36.57M | 57.32M | 0 | 108.73M | 117.26M | 94.93M | 39.15M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -7.82M | -5.98M | 2.35M | -8.12M | -11.10M | -9.67M | 0 | 1.76M | 0 |
Inventories | 0 | 2.58M | -3.65M | -284K | -545K | -596K | -2.02M | 0 | 0 | 0 |
Accounts payable | 449K | -4.73M | -902K | -7.10M | -1.52M | -7.00M | 7.65M | 2.23M | 2.80M | 4.30M |
Cash generated by operating activities | 27.00M | -15.8M | 20.7M | 800K | 22.4M | -24.1M | -172.5M | -141.7M | -154.5M | -77.2M |
Investing activities | ||||||||||
Purchases Of Investments | -23.81M | -4.83M | -38.07M | -29.82M | -127.19M | -107.50M | -79.72M | -81.79M | -214.80M | -132.25M |
Investments In Property Plant And Equipment | 0 | -7M | 0 | -20.04M | -306K | -609K | -50.43M | -7.28M | -1.18M | -1.29M |
Acquisitions Net | 0 | 0 | 0 | 20M | 0 | 193K | 36K | 15K | -37K | -25K |
Cash generated by investing activities | -19.12M | 7.1M | -10.9M | 23.3M | 5.2M | -57.6M | -15.4M | 142.2M | -85.9M | -63.3M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 12.5M | 0 | 68K | 1.35M | 0 | 26.68M | 161.85M | 205.13M | 129.44M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -100M | -8.44M | -60.62M | 0 | 50M | 0 | 0 | 0 |
Cash used in financing activities | 0 | 12.2M | -31.9M | 100K | -67.1M | 108.4M | 75.1M | 162.4M | 233.36M | 136M |
Net Change In Cash | 7.88M | 3.5M | -22.16M | 24.24M | -39.52M | 26.72M | -112.79M | 162.92M | -6.97M | -4.50M |
Cash at end of period | 86.67M | 78.79M | 75.29M | 97.45M | 73.21M | 112.73M | 81.69M | 194.49M | 31.56M | 38.53M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |